New office deepens partnership with the National Pension Service and strengthens presence in KoreaJEONJU, South Korea, June 04, 2025 (GLOBE NEWSWIRE) -- StepStone Group (Nasdaq: STEP), a global private markets solutions provider, has opened an office in Jeonju, North Jeolla Province, South Korea. The new office marks a continued expansion of StepStone’s long-standing relationship with the National Pension Service (NPS), one of the world’s largest institutional investors. This is StepStone’s second office in ...

Core Insights - Enphase Energy, Inc. announced significant commercial projects in Florida, Rhode Island, and California, totaling nearly 3 MW capacity, utilizing their IQ8P-3P™ Commercial Microinverters made with domestic content [1][2][5] Group 1: Project Details - The solar installation at the Manatee School for the Arts in Florida is projected to be one of the largest rooftop solar projects in the state, featuring a 2 MW system with 3,200 IQ8P-3P Microinverters, expected to produce over 3,800,000 kWh annually and save approximately $900,000 per year [2][3] - Rock Ridge Homes in Rhode Island will have a 666 kW solar installation with 1,282 IQ8P-3P Microinverters across 14 buildings, with construction set to begin soon [3][4] - A 150 kW solar project for the Modesto Gospel Mission in California is expected to offset about 45% of the building's energy load, providing over $1 million in lifetime savings [4][5] Group 2: Economic and Environmental Impact - The projects are designed to reduce utility costs significantly, with a goal of a 90% reduction in costs for the Manatee School for the Arts, allowing for enhanced educational programs and facilities [3] - The use of domestic content in Enphase microinverters allows projects to qualify for federal tax incentives, improving project economics and supporting American manufacturing [1][5] Group 3: Company Overview - Enphase Energy is a leading supplier of microinverter-based solar and battery systems, having shipped approximately 81.5 million microinverters and deployed around 4.8 million Enphase-based systems in over 160 countries [6]

Three out of four efzofitimod-treated diffuse SSc-ILD patients showed clinically important improvement based on the modified Rodnan Skin Score (mRSS) assessment at 12 weeks. Efzofitimod was generally safe and well tolerated at all doses. SAN DIEGO, June 04, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) ("aTyr" or the "Company"), a clinical stage biotechnology company engaged in the discovery and development of first-in- class medicines from its proprietary tRNA synthetase platform, today announc ...

Core Viewpoint - Elicio Therapeutics has secured a $10 million senior secured promissory note to extend its operational runway into Q1 2026, supporting its clinical development initiatives, particularly the AMPLIFY-7P Phase 2 interim analysis expected in Q3 2025 [2][4]. Financial Summary - The company received gross proceeds of $10 million from the Note Financing, which bears an interest rate of up to 12.5% and matures on June 3, 2028 [3]. - The financing includes a 24-month interest-only period, with interest accrued during the first 12 months payable in a lump sum starting from the thirteenth month [3]. Product Development - Elicio's lead product candidate, ELI-002, targets mKRAS-driven tumors, which account for approximately 25% of all solid tumors [4][5]. - ELI-002 is currently being studied in a randomized clinical trial for mKRAS-positive pancreatic cancer and has shown promising Phase 1 data, including a 16.3-month median recurrence-free survival and a 28.9-month median overall survival [4][6]. Technology Platform - Elicio's proprietary Amphiphile (AMP) platform is designed to enhance the education and activation of cancer-specific T cells, aiming for durable cancer immunosurveillance [4][7]. - The AMP technology allows for targeted delivery of immunotherapeutics to lymph nodes, potentially leading to superior clinical outcomes compared to conventional therapies [7][8]. Future Plans - The company plans to explore combination regimens for ELI-002 in treating pancreatic ductal adenocarcinoma (PDAC) and colorectal cancer, leveraging robust interest from clinical investigators [4]. - Elicio intends to expand ELI-002 to other indications, including mKRAS-positive lung cancer, and is developing additional off-the-shelf therapeutic cancer vaccine candidates [4][6].

SHENZHEN, China, June 04, 2025 (GLOBE NEWSWIRE) -- Fangdd Network Group Ltd. (Nasdaq: DUO) ("FangDD" or the "Company"), a customer-oriented property technology company in China, today announced that its share consolidation ("Share Consolidation"), involving the consolidation of every 16 ordinary shares with a par value of US$0.0005625 per share, into 1 ordinary share with a par value of US$0.009 per share, will take effect at 8:00 a.m. Eastern Time on June 9, 2025. The Company's Class A ordinary shares will ...

About Mizuho Americas Mizuho Financial Group, Inc. is one of the largest financial institutions in the world as measured by total assets of ~$2 trillion, according to S&P Global 2024. Mizuho's 65,000 employees worldwide offer comprehensive financial services to clients in 36 countries and 850 offices throughout the Americas, EMEA, and Asia. Mizuho Americas is a leading Corporate and Investment Bank (CIB) that provides a full spectrum of client- driven solutions across strategic advisory, capital markets, co ...

AB "ŽEMAITIJOS PIENAS" received a notification of a transaction involving the issuer's securities by a person in a managerial position (see attachment). Person authorized to provide additional information: Arnas Matuzas Head of Legal Email: a.matuzas@zpienas.lt Attachment Notification_ZP ...

SINGAPORE, June 04, 2025 (GLOBE NEWSWIRE) -- BitFuFu Inc. ("BitFuFu" or the "Company") (NASDAQ: FUFU), a world-leading Bitcoin miner and mining services innovator, today announced its unaudited production and mining operation updates for May 2025. Hashrate Overview Power and Infrastructure Total Power Capacity Under Management: 651 MW across five continents, a 15.0% month-over- month increase. Mining Services "To meet the continued strong demand for cloud mining services, in May we further expanded our hash ...

LAS VEGAS, June 04, 2025 (GLOBE NEWSWIRE) -- Asia Broadband Inc. (OTC: AABB) ("AABB" or the "Company") announced today that the Company's management and Board of Directors have approved a new stock dividend. The common share dividend will be distributed on the basis of 1 dividend share for every 35 shares owned representing over 100 million restricted shares to be distributed. AABB management is currently finalizing the imminent dividend record date and the distribution details with its transfer agent. Furt ...

Medicinal leeches are increasingly used in the GCC to treat diverse medical conditions including venous congestion, which is a buildup of blood in the veins, and to aid in tissue healing and circulation following reconstructive and microsurgery procedures. The leeches are also used to relieve symptoms of osteoarthritis as well as in veterinary surgery, especially to help treat polycythaemia vera, a chronic blood cancer. "We are excited to complete both of these milestones," said Cuprina chief executive Davi ...